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The genes coding for the five outer membrane proteins (OMPs) of the Omp25/Omp31 family expected to be
located in the outer membrane (OM) of rough virulent Brucella ovis PA were inactivated to evaluate their role
in virulence and OM properties. The OM properties of the mutant strains and of the mutants complemented
with the corresponding wild-type genes were analyzed, in comparison with the parental strain and rough B.
abortus RB51, in several tests: (i) binding of anti-Omp25 and anti-Omp31 monoclonal antibodies, (ii) auto-
agglutination of bacterial suspensions, and (iii) assessment of susceptibility to polymyxin B, sodium deoxy-
cholate, hydrogen peroxide, and nonimmune ram serum. A tight balance of the members of the Omp25/Omp31
family was seen to be essential for the stability of the B. ovis OM, and important differences between the OMs
of B. ovis PA and B. abortus RB51 rough strains were observed. Regarding virulence, the absence of Omp25d
and Omp22 from the OM of B. ovis PA led to a drastic reduction in spleen colonization in mice. While the
greater susceptibility of the omp22 mutant to nonimmune serum and its difficulty in surviving in the
stationary phase might be on the basis of its dramatic attenuation, no defects in the OM able to explain
the attenuation of the omp25d mutant were found, especially considering that the fully virulent omp25c
mutant displayed more important OM defects. Accordingly, Omp25d, and perhaps Omp22, could be directly
involved in the penetration and/or survival of B. ovis inside host cells. This aspect, together with the role of
Omp25d and Omp22 in the virulence both of B. ovis in rams and of other Brucella species, should be thoroughly
evaluated in future studies.
The genus Brucella comprises six classical species (Brucella
melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae)
that infect terrestrial mammals (41), although in recent years
an increasing number of Brucella strains have been isolated
from marine mammals and proposed to be included in two new
species, B. cetaceae and B. pinnipediae (9).
Brucella spp. may have smooth or rough lipopolysaccharide
(S-LPS or R-LPS) depending on the presence or absence,
respectively, of O-polysaccharide chains. Rough mutants de-
rived from smooth Brucella strains show an important reduc-
tion in virulence (1, 26, 30, 40, 45). Accordingly, the O-poly-
saccharide chains of LPS are thought to be necessary for the
pathogenicity of Brucella strains bearing S-LPS. However, B.
ovis and B. canis lack O chains in the LPS but are pathogenic
for rams and dogs, respectively, and induce long-lasting infec-
tions with high levels of splenic colonization in laboratory
animals (34). Since O chains mask other components of the
Brucella spp. outer membrane (OM), OM proteins (OMPs)
are more exposed at the bacterial surface of rough B. ovis and
B. canis (4, 7) and their involvement in virulence in rough
Brucella strains may be more relevant than in smooth Brucella
strains.
The Brucella spp. Omp25/Omp31 family comprises seven
homologous OMPs. Omp25 and Omp31 are major OMPs,
except Omp31 in B. abortus, which lacks its coding gene (48,
49, 51), and they have been fairly well characterized in several
aspects (11). Regarding virulence, mutant B. melitensis, B.
abortus, and B. ovis strains with the omp25 gene inactivated
have been found to be attenuated in mice, goats (B. melitensis),
and cattle (B. abortus) (17–19). Additionally, Omp25 has been
shown to inhibit the production of tumor necrosis factor alpha
(TNF-) by human macrophages (35) and to be involved in the
permeability of the Brucella membrane, allowing the secretion
of periplasmic proteins, in acidic medium (3).
In contrast, little is known about the Omp31b, Omp25b,
Omp25c, Omp25d, and Omp22 proteins. Although no studies
specifically analyzing the presence of these proteins in each
Brucella species have been reported, the five OMPs have been
detected experimentally in at least one Brucella species. Thus,
Omp31b has been identified in B. abortus and B. suis (13, 42),
Omp25b in B. melitensis and B. suis (23, 42, 52), Omp25c in B.
melitensis, B. abortus, and B. suis (13, 42, 52), and Omp22 in B.
abortus (13, 32). Evidence for the production of Omp25d in the
genus Brucella is less conclusive, since the protein has been
detected only weakly, by reactivity with an anti-Omp25 mono-
clonal antibody (MAb), in an omp25-defective B. suis mutant
(42). Studies addressing DNA polymorphism of the Omp25/
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Omp31-encoding gene family in the genus Brucella have pro-
vided additional information about the occurrence of these five
proteins in the OM of the Brucella species (46): (i) Omp31b is
probably absent from the OMs of B. melitensis, B. ovis, and B.
canis; (ii) Omp25b is not expected to be present in the OMs of
B. abortus, B. ovis, B. canis, B. cetaceae, and B. pinnipediae; and
(iii) Omp25c, Omp25d, and Omp22 are conserved proteins
that would be located in the OMs of the six classical Brucella
species and of B. cetaceae and B. pinnipediae (perhaps with the
exception of Omp22 in some B. cetaceae isolates).
In the present work, we evaluated the role of the five mem-
bers of the Omp25/Omp31 family expected to be located in the
OM of B. ovis (46) in terms of the OM properties and virulence
of the bacterium. To achieve these objectives, single-mutant
strains with the genes omp31, omp25, omp25c, omp25d, or
omp22 inactivated were obtained from virulent B. ovis PA and
were subsequently complemented with the corresponding wild-
type genes.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and cloning vectors. The Brucella strains
used in this work are listed in Table 1 and were cultured at 37°C in a 10% CO2
atmosphere. They were typically propagated in tryptic soy broth (TSB; Difco
Laboratories, Detroit, MI) or tryptic soy agar (TSA; Difco Laboratories), both
supplemented with 0.3% yeast extract (YE; Difco Laboratories) and 5% horse
serum (HS; GIBCO-BRL Life Technologies, Germany) (TSB-YE-HS and TSA-
YE-HS). For bacteriological typing and virulence experiments, blood agar base
no. 2 (Biolife, Italy) supplemented with 5% calf serum (Seromed; Biochrom,
Austria) was used. Kanamycin (Kan; 50 g/ml) or Kan plus ampicillin (Amp) (50
g/ml each) was added to the culture medium used for mutant or complemented
mutant strains of B. ovis PA, respectively. When necessary for the selection of
mutant strains, the medium was supplemented with 5% sucrose or Amp (50
g/ml). Bacteriological typing of the B. ovis mutant and complemented strains
obtained in this work was performed using standard procedures (i.e., Gram
staining; catalase, oxidase, urease, and acriflavine agglutination testing; lysis by
Tb, Wb, Iz, and R/C phages; agglutination with anti-A and anti-M monospecific
sera; CO2 and serum dependence testing; and testing of susceptibility to thio-
nine, fuchsine, and safranine) (2).
Plasmids pGEM-T Easy (Promega, Madison, WI), pGEM7-Zf (Promega),
pUC19 (Fermentas), pCVD442 (16), and pBBR1MCS-4 (36) were used as
cloning vectors. Plasmid pCVD442 does not replicate in Brucella spp., confers
resistance to Amp, and contains sacB gene, which renders bacteria susceptible to
sucrose, while pBBR1MCS-4 replicates in Brucella spp. and confers Amp
resistance. The plasmids were propagated either in Escherichia coli JM109 (Pro-
mega) or, in the case of pCVD442-derived plasmids, in E. coli CC118 (pir).
Recombinant E. coli cells were grown in Luria-Bertani medium supplemented
with 50 g/ml of the required antibiotic(s) depending on the plasmid.
Primers and DNA techniques. Primers (Roche, Germany) (Table 2) were
chosen according to the published B. melitensis 16 M and B. suis 1330 nucleotide
TABLE 1. Brucella strains used in this work
Brucella strain Relevant genotype Relevant characteristic(s) Origin
Wild-type strainsa
B. abortus RB51 Rough strain obtained under laboratory conditions BCCNb
B. ovis PA Parental strain Naturally rough virulent Brucella strain BCCN
Mutant strains
B. ovis PNV31A omp31 Kanr B. ovis PA with a Kan resistance cassette replacing the XcmI-SalI
fragment of omp31
This work
B. ovis PNV25A omp25::Kanr B. ovis PA with a Kan resistance cassette inserted into the AflII
site of omp25
This work
B. ovis PNV25cA omp25c Kanr B. ovis PA with a Kan resistance cassette replacing the AspI-
HinCII fragment of omp25c
This work
B. ovis PNV25dA omp25d Kanr B. ovis PA with a Kan resistance cassette replacing the NheI-ClaI
fragment of omp25d
This work
B. ovis PNV22A omp22 Kanr B. ovis PA with a Kan resistance cassette replacing the RsrII-StuI
fragment of omp22
This work
Complemented mutant
strains
B. ovis PNV31A-com omp31 omp31 Kanr Ampr B. ovis PNV31A complemented with omp31 cloned in pNV31300c This work
B. ovis PNV25A-com omp25::Kanr omp25 Kanr Ampr B. ovis PNV25A complemented with omp25 cloned in pNV25comc This work
B. ovis PNV25cA-com omp25c omp25c Kanr Ampr B. ovis PNV25cA complemented with omp25c cloned in pNV25c4c This work
B. ovis PNV25dA-com omp25d omp25d Kanr Ampr B. ovis PNV25dA complemented with omp25d cloned in pNV25d4c This work
B. ovis PNV22A-com omp22 omp22 Kanr Ampr B. ovis PNV22A complemented with omp22 cloned in pNV22Dc This work
a Reference strains of the Brucella species (46) were also used for the bacteriological typing of the B. ovis strains obtained in this work.
b BCCN, Brucella Culture Collection of Nouzilly, INRA Centre de Tours, France. B. abortus RB51 and B. ovis PA are strains BCCN V5 and BCCN 76-250,
respectively.
c Plasmids were constructed by cloning the corresponding B. ovis PA wild-type omp gene in pBBR1MCS-4.
TABLE 2. DNA primers used in this study
Primer use and name Nucleotide sequence
Construction of mutant
B. ovis PA strains
31MUT-F .......................................5-AGA ATA AAA CAC ATG CCC-3
31MUT-R ......................................5-GCT GAA TGC GGA GAT GGT-3
25MUTZ-F ....................................5-CGA CCT TAT CCT CCT GAA-3
25MUTZ-R....................................5-CCA GCA AAA CGT CGC AAA-3
25cdMUT-F ...................................5-TGC GTG GTT CAG ATT TCG-3
25cdMUT-R ..................................5-TTG CCG CTT CCA TCA GGT-3
25cMUT-R.....................................5-AGC CGT AAC CAA CCT GAC-3
22MUT-F .......................................5-GGC AAA GAA GAA GAA TAC-3
22MUT-R ......................................5-CTG CTG GAA TGC CCT GAA-3
Complementation of
mutant B. ovis
PA strains
31sd.................................................5-TGA CAG ACT TTT TCG CCG AA-3
31ter................................................5-CAT TCA GGA CAA TTC CCG CC-3
25A-F..............................................5-GGA CCG CGC AAA ACG TAA-3
25-R ................................................5-ACC GGA TGC CTG AAA TCC-3
25C-F..............................................5-CTG TGT CCT GTT TGC TAC-3
25C-R .............................................5-TAT TGG GTG AGG ATT GAC-3
25D-F .............................................5-CTA CAT ACA TTC GAC CAG-3
25D-R.............................................5-CTG AAG GGT AAA TGC GGC-3
22-F.................................................5-TCA AGC ATG TTT CCC GCC-3
22-R ................................................5-GTT TGA ATC CCG GCT GTT-3
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sequences for chromosomes I and II (GenBank accession numbers AE008917,
AE008918, AE014291, and AE014292). PCR was performed with the Expand
Long Template PCR system (Roche) following the instructions of the manufac-
turer with 100 ng of B. ovis strain DNA template extracted with a High Pure PCR
template preparation kit (Roche) and 2 M each primer. DNA was sequenced
by primer-directed dideoxy sequencing with an ABI PRISM 377 DNA sequencer
(Perkin-Elmer, Foster City, CA).
Southern blot hybridization was performed as described previously (46) using
digoxigenin (DIG)-labeled probes and B. ovis strain chromosomal DNA digested
with HindIII. Probes were labeled with a DIG DNA labeling kit (Roche), and
hybridization was detected with a DIG nucleic acid detection kit (Roche) as
instructed by the manufacturer. DNA markers III and VI (Roche) were used as
molecular size standards and were hybridized with probes constituted by the
same markers labeled with DIG.
MAbs and immunological techniques. MAbs A59/05F01/C09 (C09) and A19/
12B10/F04 (F04) (ascitic fluid), specific for Brucella sp. Omp25, and A59/10F09/
G10 (G10) and A01/08H06/G02 (G02) (hybridoma culture medium superna-
tant), specific for Brucella spp. Omp31 (7, 50), were used. Western blotting with
Brucella whole-cell lysates was performed as described previously (50). For
indirect enzyme-linked immunosorbent assay (iELISA) (46), parental or mutant
B. ovis PA strains cultured for 24 h in the corresponding TSB-YE-HS media and
washed with phosphate-buffered saline (PBS; pH 7.2) were used as coating
antigens (100 l/well of a bacterial suspension adjusted to an optical density at
600 nm [OD600] of 1). Then, a saturation step with 5% skim milk in PBS was
included (300 l/well; 30 min at 37°C). After subsequent incubation steps with
MAbs and goat anti-mouse immunoglobulin G (Fc-specific) peroxidase conju-
gate (Sigma, St. Louis, Mo.; 1:4,000), OD405 values were recorded after 30 min
of incubation with the substrate solution, and the results were expressed as the
mean  standard deviation (SD) of the OD readings for three wells.
Inactivation of the genes encoding the Omp25/Omp31 family in B. ovis PA by
homologous recombination. In this work, we obtained five mutant strains (Table
1) derived from parental B. ovis PA by individually inactivating the genes coding
for Omp31, Omp25, Omp25c, Omp25d, and Omp22 (genes BRA0423, BR0701,
BR0119, BR0118, and BR1284, respectively, according to the B. suis 1330 ge-
nome sequence). For all the genes except omp25, inactivation was performed by
replacing most of the gene by a Kan resistance cassette, which was placed in the
direction opposite to that of the gene. Inactivation of omp25 was achieved by
insertion of the Kan resistance cassette, also in the direction opposite to that of
the gene, at the AflII site located just 10 nucleotides downstream from the omp25
ATG start codon.
Briefly, deletion of omp31 from parental B. ovis PA was performed as follows.
Primers 31MUT-F and 31MUT-R (Table 2) were used to amplify, according to
the B. melitensis 16 M sequence (49), a 1,406-bp fragment comprising omp31 and
DNA flanking both sides of the gene. The amplified fragment was cloned into
plasmid pGEM-T Easy, excised by EcoRI digestion from the recombinant plas-
mid obtained, and then cloned into the EcoRI site of pGEM7-Zf. Then, the
XcmI-SalI fragment of omp31 was replaced from the resulting pNV31201 re-
combinant plasmid by the Kanr gene extracted from pUC4K (Amersham Bio-
sciences) to give pNV31211. The DNA insert of pNV31211 was isolated by
digestion with SphI and SacI and cloned into pCVD442, resulting in
pNV31211-1, which was introduced into B. ovis PA by electroporation as de-
scribed previously (46). To replace wild-type omp31 by the inactivated omp31
gene of pNV31211-1 from the B. ovis chromosome by double recombination
through the homologous regions flanking both sides of omp31, a previously
described procedure was followed (21). Mutant B. ovis PNV31A (omp31) was
selected by both its resistance to Kan and sucrose and by its susceptibility
to Amp.
A similar process was followed to inactivate the other genes, and only the
significant differences are mentioned below. The primers used for the inactiva-
tion of the other genes (Table 2) were as follows: 25MUTZ-F and 25MUTZ-R
(omp25), 25cdMUT-F and 25cMUT-R (omp25c), 25cdMUT-F and 25cdMUT-R
(omp25d), and 22MUT-F and 22MUT-R (omp22). Plasmids pNV25mut-1,
pNV25c-1, pNV25d-2, and pNV22-1 were the pCVD442-derived plasmids used
to electroporate B. ovis PA to obtain the mutant strains described in Table 1.
These plasmids respectively contained the omp25, omp25c, omp25d, and omp22
genes inactivated by the Kan resistance cassette, as shown in Table 1, column 3.
To check the mutant strains, a chromosomal region including the entire frag-
ment used to inactivate the omp gene and adjacent DNA on both sides was PCR
amplified and sequenced. Southern blot hybridization of HindIII-digested
chromosomal DNA with pCVD442 and either pNV31211-1, pNV25mut-1,
pNV25c-1, pNV25d-2, or pNV22-1 DIG-labeled probes was also performed. The
absence of Omp31 and Omp25 from B. ovis PNV31A and B. ovis PNV25A
(Table 1), respectively, was checked by Western blotting with MAbs G02 and
C09. CFU in medium with and without Kan were determined for each mutant
strain in order to evaluate the stability of the mutations in vitro.
Complementation of mutant strains. Mutant B. ovis PA strains were comple-
mented with the corresponding wild-type genes. Each gene, including the ribo-
some binding site and the transcription terminator, was PCR amplified with
primers 31sd and 31ter (omp31), 25A-F and 25-R (omp25), 25C-F and 25C-R
(omp25c), 25D-F and 25D-R (omp25d), or 22-F and 22-R (omp22) (Table 2).
PCR products were cloned in pGEM-T Easy, and the DNA inserts of the
selected plasmids were subsequently cloned in pBBR1MCS-4 to leave the omp
genes under the control of the lacZ promoter. Recombinant pBBR1MCS-4
derivatives pNV31300, pNV25com, pNV25c4, pNV25d4, and pNV22D were
introduced in the corresponding mutant B. ovis PA strain by electroporation, and
colonies resistant to both Amp and Kan were selected (Table 1). Complemen-
tation was verified by extraction of the plasmid DNA and sequencing of the DNA
insert. Synthesis of Omp31 in B. ovis PNV31A-com and of Omp25 in B. ovis
PNV25A-com (Table 1) was also confirmed by reactivity with the MAbs G02 and
C09 in Western blotting assays. Plasmid stability of the complemented mutant
strains was tested by plating in culture medium without antibiotic or with Kan
and Amp.
Susceptibility assays. For susceptibility assays, B. ovis strains and B. abortus
RB51 were cultured for 44 and 24 h, respectively, on TSA-YE-HS supplemented
with antibiotic(s) when required. Then, a bacterial suspension was prepared in
PBS as detailed for each test.
The susceptibilities of Brucella strains to polymyxin B (Sigma) and sodium
deoxycholate (Sigma) were determined following a protocol described previously
(38) with some modifications. A bacterial suspension containing approximately
1  104 CFU/ml was prepared in PBS, and 100 l was mixed in wells of a 96-well
sterile plate with 100 l of 2 mg/ml polymyxin B or 0.2 mg/ml sodium deoxy-
cholate (final concentrations in the wells, 1 mg/ml and 0.1 mg/ml, respectively).
After a 1-h incubation at 37°C in a 10% CO2 atmosphere, the content of each
well was mixed, and 50 l was spread in triplicate on TSA-YE-HS plates sup-
plemented with antibiotic(s) when required. The CFU obtained after treatment
with polymyxin B or sodium deoxycholate were counted, and the percentages of
survival were established with respect to the CFU obtained with bacteria incu-
bated in PBS (100% survival). The results were expressed as the mean  SD of
three assays.
Susceptibility to hydrogen peroxide (Sigma) was evaluated by a modification of
the disk sensitivity assay described by Elzer et al. in 1994 (22). A bacterial
suspension with approximately 109 CFU/ml (OD600 of 0.2) was prepared in PBS,
and 100 l was spread by triplicate on TSA-YE-HS plates supplemented with
antibiotic(s) when required. A Whatman 3MM Chr disk (9-mm diameter) was
placed at the center of the plate, and 10 l of 30% H2O2 was deposited on the
disk. After 4 days of growth, the diameter of the zone of clearance around the
disk was measured in quadruplicate for each plate and the mean diameter was
calculated. The results were expressed as the mean SD of the diameter (in cm)
obtained for the three plates.
The protocol designed to determine the susceptibility of the Brucella strains to
nonimmune ram serum was based on that described by Corbeil et al. in 1988 (14).
Serum was obtained from a 5-month-old ram born in the brucellosis-free flock of
the Centro de Investigacio´n y Tecnologı´a Alimentaria (CITA) del Gobierno de
Arago´n, Spain. Half of the serum was heated at 56°C for 30 min to remove
complement (control serum) and the other half was used fresh. Briefly, 50-l
bacterial suspensions with approximately 2  104 CFU/ml in PBS were mixed in
wells of a 96-well sterile plate with 150 l of either fresh serum or heated serum.
After a 4-h incubation at 37°C in a 10% CO2 atmosphere, the content of each
well was gently mixed by pipetting and 50 l of each bacterial suspension was
spread in triplicate on TSA-YE-HS plates supplemented with antibiotic(s) when
required. The CFU obtained after exposure to fresh serum were counted, and
the percentages of survival were established with respect to the CFU obtained
with the heated serum (100% survival). The results were expressed as the mean 
SD of three assays performed with the same serum.
Autoagglutination test. Bacterial suspensions with an OD600 of 0.8 were pre-
pared in TSB-YE-HS from B. ovis strains previously cultured for 44 h (or from
B. abortus RB51 cultured for 24 h) in TSA-YE-HS supplemented with the
corresponding antibiotic(s). One ml of each suspension was left in a spectropho-
tometer microcuvette without agitation, and the OD600 readings were scored for
45 h at selected intervals. One microcuvette with TSB-YE-HS was used as a
blank. The results were represented as the mean  SD of the values obtained for
three assays at each time point.
Virulence studies in mice. Female 8-week-old BALB/c mice (Charles River
Laboratories, Spain) were accommodated in the animal building of the CITA of
Arago´n (registration number ES-502970012005) under biosafety conditions. The
animals were kept in cages with water and food ad libitum for 1 week before the
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start of the experiment. The mouse experimental procedures and the facilities
used to hold the mice were in accordance with current European legislation
(directive 86/609/EEC).
After a preliminary assay to determine the most adequate dose of infection,
mice were inoculated intraperitoneally with approximately 5  106 CFU of the
corresponding B. ovis strain in 0.1 ml of PBS, and splenic bacterial counts were
determined for five mice per strain at 1, 2, 3, 5, 7, 9, and 11 weeks postinoculation
(p.i.). Experimental procedures (i.e., preparation and administration of inocula,
retrospective assessment of the exact inoculating doses, and determination of the
number of CFU/spleen) were performed as described previously (12). The num-
bers of CFU/spleen were transformed logarithmically to normalize the distribu-
tion of individual counts. Results were expressed as the mean  SD (n 	 5) of
the log CFU/spleen for each strain at each selected p.i. time point.
To check the stability of mutation after in vivo activity, the strains recovered
from the spleens of infected mice were rechecked by PCR amplification, South-
ern blot hybridization, plating in culture medium with or without the required
antibiotic, bacteriological typing, and Western blot assays as described above.
Statistical analysis. Statistical comparisons between means were performed
using analysis of variance, and the levels of significance of the differences were
determined with the post hoc Fisher’s protected least significant differences test.
RESULTS
Inactivation of the genes encoding the Omp25/Omp31 fam-
ily in B. ovis PA and complementation of the mutant strains.
DNA sequencing and Southern blot hybridization with chro-
mosomal DNA extracted from the five B. ovis PA mutant
strains afforded the expected results for inactivation of the
corresponding genes, with no modification of adjacent genes.
Plasmid DNA could be isolated from the mutant strains com-
plemented with the corresponding wild-type genes, and the
insert DNA had the expected nucleotide sequence. After both
in vitro subculturing and in vivo activity in mice, all the genet-
ically modified B. ovis PA strains behaved like the B. ovis PA
parental strain in the standard tests for Brucella spp. typing and
gave similar CFU counts in TSA-YE-HS with and without
antibiotic, thus showing the stability of the mutation or
complementation. By transmission electron microscopy, no de-
fects were found in the cell wall structures of any of the mutant
strains (data not shown).
In vitro growth on solid (TSA-YE-HS) and in liquid (TSB-
YE-HS) media was not, in general, dramatically affected for
the genetically modified B. ovis PA strains. The number of
CFU/ml was determined for bacterial suspensions of an OD600
of 0.2 prepared from bacteria cultured for 44 h on TSA-YE-HS
plates. B. ovis omp25d and omp22 mutants and their derived
complemented strains had counts similar to that obtained with
parental B. ovis PA, while omp31 and omp25c mutant
strains and their respective complemented strains had CFU/ml
values about half as high (the omp31 and omp31-com
strains also required one more day than the other strains to
develop visible colonies on solid medium) (data not shown).
The omp25 mutant strain also afforded CFU/ml values about
half as high as those observed with the parental strain, but
complementation of this mutant with wild-type omp25 recov-
ered the counts obtained with B. ovis PA (data not shown).
Growth in liquid medium of bacterial cultures starting at an
OD600 of 0.05 and incubated with shaking is shown in Fig. 1.
The omp31 and omp25 mutant strains, in spite of reaching
higher OD values (Fig. 1A), provided CFU/ml numbers in the
stationary phase similar to that observed for parental B. ovis
PA (data not shown). The omp25c strain seemed to grow
slower than the parental strain, reaching OD600 and CFU/ml
values in the stationary phase that were slightly lower than
those corresponding to B. ovis PA. As determined by OD600
readings and CFU/ml counts, the omp25d mutant grew as
well as the parental strain did (Fig. 1A and data not shown).
The omp22 mutant grew faster than B. ovis PA, reaching the
stationary phase earlier (Fig. 1B). However, although the bac-
terial counts for the omp22 mutant were in accordance with
the OD600 scores and both parameters were higher than those
observed with B. ovis PA up to 25 h of incubation, the number
of CFU/ml for this mutant underwent a drastic decrease after
46 h of culture; at this time point, it was almost 2 logs lower
than that obtained for this mutant at 25 h and that obtained for
the parental strain after 46 h of incubation (Fig. 1B).
The absence of Omp31 and of Omp25 in the respective
mutant strains and the recovery of their synthesis in the cor-
responding complemented mutant strains were verified by re-
activity with specific MAbs (Fig. 2). Moreover, by reactivity
with rabbit polyclonal antibodies raised against the recombi-
nant proteins of the Omp25/Omp31 family, we obtained addi-
tional information about the synthesis of the other members of
the Omp25/Omp31 family in the B. ovis strains obtained in this
work (unpublished results). Thus, we were able to detect the
presence of Omp25c and Omp22 in B. ovis PA and their ab-
sence in the respective mutant strains. Moreover, Omp25c was
detected at important levels—higher than those detected for
the parental strain—for the complemented mutant strain B.
ovis PNV25cA-com. In contrast, the synthesis of Omp22 was
strongly decreased in the complemented mutant strain B. ovis
PNV22A-com compared with parental B. ovis PA. Unfortu-
nately, attempts to detect Omp25d have been unsuccessful so
far, and hence we were not able to identify this protein either
FIG. 1. Growth curves in liquid TSB-YE-HS, as determined by the
evolution of OD600 with time, of parental B. ovis PA (A and B) and the
mutant strains with the genes omp31, omp25, omp25c, omp25d (A),
and omp22 (B) inactivated. CFU/ml counts are shown at time points 25
and 46 h for parental and omp22 mutant strains (B). Cultures were
started at an OD600 of 0.05 and were incubated at 37°C with shaking
under a 10% CO2 atmosphere.
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in the parental strain or in the complemented mutant strain
PNV25dA-com.
Effect of the inactivation of each gene encoding the Omp25/
Omp31 family on the levels of Omp25 and Omp31 in B. ovis
PA. The five mutant strains derived from B. ovis PA and the
mutant strains complemented with the corresponding wild-
type genes (Table 1) were analyzed by iELISA and Western
blotting with MAbs specific for the Omp31 and Omp25 pro-
teins (the only proteins of the Omp25/Omp31 family for which
MAbs are available) in order to determine both the absence of
Omp31 and Omp25 in B. ovis PA mutant strains PNV31A and
PNV25A, respectively, and how the inactivation of each gene
coding for the Omp25/Omp31 family might affect the amount
of and/or accessibility to antibodies of these two major OMPs.
The Omp31 protein afforded the characteristic multiple-band
pattern in Western blotting (47, 50) with the specific MAb (Fig.
2A). As expected, Omp31 was not detected in the omp31
mutant strain by Western blotting (Fig. 2A) or by iELISA (Fig.
2C), and complementation of this strain with wild-type omp31
restored the synthesis of Omp31 (Fig. 2A and C). Upon com-
paring B. ovis PNV31A-com to parental B. ovis PA, however,
slight differences regarding the reactivity of the anti-Omp31
MAbs were found as follows. (i) MAb G02 showed, in both
Western blotting and iELISA, a weaker reactivity with the
complemented mutant strain PNV31-com (Fig. 2A and C)
than with the parental strain (Fig. 2A and C). (ii) Nevertheless,
strain PNV31A-com reacted slightly better than B. ovis PA
with MAb G10 in iELISA (Fig. 2C). This MAb, raised against
B. melitensis Omp31, reacts strongly with Omp31 from B. ovis
in iELISA but very weakly in Western blotting (50). The other
four mutant strains and the four respective complemented
strains behaved in manners similar to that of the parental
strain regarding reactivity with the anti-Omp31 MAbs in West-
ern blotting (Fig. 2A) and iELISA (Fig. 2C), with the exception
of B. ovis PNV25cA, which reacted more weakly in iELISA
with MAb G02 (Fig. 2C).
Likewise, Omp25 was not detected in the B. ovis PNV25A
mutant strain by Western blotting or by iELISA with a specific
MAb (Fig. 2B and D), and the recovery of the synthesis of the
protein was detected in the complemented strain B. ovis
PNV25A-com (Fig. 2B and D). Anti-Omp25 MAb C09 devel-
oped in Western blotting two protein bands in parental B. ovis
PA that correspond to Omp25, as previously shown (10, 29).
These Omp25 protein bands were more intensely marked both
in mutant B. ovis PNV31A and in its corresponding strain
complemented with wild-type omp31 (Fig. 2B) than in the
other mutant or complemented strains (Fig. 2B), which dis-
played the same band profile as the parental strain (Fig. 2B).
With regard to iELISA, further differences were found be-
tween strains in the reactivity with the two anti-Omp25 MAbs
(Fig. 2D). Thus, while the omp31 strain and its comple-
mented strain showed slightly higher reactivity with MAb C09,
inactivation of omp25c, omp25d, and omp22 led to a lower
reactivity with this MAb, which persisted after complementa-
tion with the respective wild-type genes (Fig. 2D). The oppo-
site situation was observed with MAb F04. This MAb did not
react with parental B. ovis PA or with the derived PNV25A or
PNV25A-com strains. The absence of reactivity with parental
and PNV25A-com complemented strains was not surprising,
since MAb F04 was previously shown to react in ELISA much
FIG. 2. Western blot (A and B) and iELISA (C and D) analysis of the B. ovis strains obtained in this work. Western blotting was performed
with MAb G02, specific for the B. ovis Omp31 protein, diluted 1/5 (A) or with MAb C09, specific for the Brucella spp. Omp25 protein, diluted
1/6,000 (B). The positions of the molecular mass protein standards are shown by arrows on the left. For iELISA, MAbs specific for Omp31 (G02
and G10, diluted 1/50) (C) or specific for Omp25 (C09, diluted 1/6,400, and F04, diluted 1/800) (D) were used. Black, white, and shaded columns
correspond to parental B. ovis PA, mutant strains, and complemented mutant strains, respectively.
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more weakly with the B. ovis Omp25 protein than with the B.
melitensis protein and not to react at all with B. ovis Omp25
located in the OM of E. coli (10). Surprisingly, however, the
mutant omp31 strain, and especially the omp25c, omp25d,
and omp22 strains, reacted intensely with MAb F04 (Fig.
2D). This was also the case for the corresponding comple-
mented mutant strains, with the exception of strains PNV31A-
com and especially PNV25cA-com, which, although showing
reactivities higher than that of the parental strain, afforded
reactions less intense than those observed for their corre-
sponding mutant strains (Fig. 2D).
Role of the proteins of the Omp25/Omp31 family in the OM
properties of B. ovis PA. Several tests related to the OM prop-
erties of Brucella spp. (i.e., autoagglutination and resistance to
polymyxin B, sodium deoxycholate, hydrogen peroxide, and
nonimmune ram serum) that might be linked to virulence were
performed with all the B. ovis strains obtained in this work, and
the results were compared with those given by parental B. ovis
PA and B. abortus RB51.
When bacterial suspensions were incubated statically at
room temperature, the parental rough strain B. ovis PA re-
mained in suspension throughout the experiment, while the
rough strain B. abortus RB51 settled quickly, showing a reduc-
tion of about 60% in the OD600 after 4 h of incubation and an
almost complete clearance after 18 h (Fig. 3). B. ovis PA
omp31 and omp25c mutant strains, and to lesser extent
mutant PNV25A, also showed a strong capacity to autoagglu-
tinate (Fig. 3). Complementation of mutant strains PNV25A
and PNV25cA with wild-type omp25 and omp25c, respectively,
restored the phenotype of the B. ovis PA parental strain. How-
ever, complementation of strain PNV31A with wild-type
omp31, although reducing its autoagglutination properties, did
not completely recover the characteristics of the parental strain
(Fig. 3). Finally, both the PNV25dA and PNV22A mutant
strains and the corresponding complemented strains behaved
like the parental strain, remaining in suspension throughout
the experiment (data not shown).
Parental B. ovis PA was relatively resistant to 1 h of exposure
to 1 mg ml
1 polymyxin B (survival of 69.59%  5.26%) while
B. abortus RB51 was completely killed after this treatment
(Table 3). B. ovis PNV25cA was the only mutant strain that was
significantly less resistant (P  0.0005) to polymyxin B than
parental B. ovis PA (survival of 27.70%  11.65% versus
69.59%  5.26%) (Table 3). The corresponding mutant strain
complemented with wild-type omp25c (survival of 7.88% 
5.18%) did not recover the resistance of parental B. ovis PA
and was even more susceptible (P  0.05) than mutant strain
PNV25cA (Table 3). B. ovis PNV22A-com was also more sus-
ceptible to polymyxin B than B. ovis PA (P  0.005) but was
not different from its corresponding mutant strain, PNV22A,
FIG. 3. Autoagglutination capacity of parental B. ovis PA, its de-
rived strains obtained in this work, and B. abortus RB51. The OD600
values for bacterial suspensions adjusted to an initial OD600 of 0.8 were
scored at several time points of static incubation, and the percent
OD600 was determined with respect to the OD600 of the initial suspen-
sion (100% of OD600). B. ovis PA mutants PNV25dA and PNV22A
and the corresponding strains complemented with wild-type omp25d
and omp22, respectively, behaved as parental B. ovis PA and are not
represented. The SD, which was always lower than 5% of the mean, is
not shown.
TABLE 3. Susceptibility to polymyxin B, sodium deoxycholate, hydrogen peroxide, and nonimmune ram serum of B. abortus RB51, parental
B. ovis PA, and its derived strains obtained in this worka
Brucella strain
% Survival after 1-h exposure to: Inhibition zone diam
(cm) with hydrogen
peroxide
% Survival after 4-h exposure
to nonimmune ram serumPolymyxin B (1 mg/ml) Na deoxycholate(0.1 mg/ml)
B. abortus RB51 0.00  0.00B 88.69  5.45 4.28  0.11C 25.73  4.84B
B. ovis PA (parental) 69.59  5.26 89.34  9.30 5.04  0.05 85.52  5.20
B. ovis PNV31A 70.07  13.83 75.51  20.97 6.23  0.11B 64.43  6.97C
B. ovis PNV31A-com 69.83  8.63 62.99  22.90D 6.64  0.37B(D) 69.44  3.62D
B. ovis PNV25A 75.73  22.13 63.81  3.98D 5.88  0.02B 71.67  2.89D
B. ovis PNV25A-com 75.42  4.41 64.74  15.67D 6.08  0.43B 87.21  2.27(D)
B. ovis PNV25cA 27.70  11.65B 39.21  7.92B 5.88  0.15B 55.68  7.32B
B. ovis PNV25cA-com 7.88  5.18B(D) 32.54  18.15B 7.08  0.04B(B) 17.51  14.17B(B)
B. ovis PNV25dA 61.16  8.93 55.44  21.69C 6.05  0.07B 54.05  7.42B
B. ovis PNV25dA-com 58.02  12.87 48.70  15.19C 6.29  0.27B 56.13  2.98B
B. ovis PNV22A 52.74  3.97 30.68  3.60B 5.90  0.25B 25.38  3.98B
B. ovis PNV22A-com 38.52  1.91C 23.31  8.23B 6.09  0.02B 17.41  5.47B
a Assays were performed as detailed in Materials and Methods. Values are means  SD (n	 3). Statistical comparisons were performed with Fisher’s protected least
significant differences test. Significant differences between the mutant or complemented strains and parental B. ovis PA or between the complemented strains and the
corresponding mutant strain (in parenthesis) are as follows: B, P  0.0005; C, P  0.005; D, P  0.05.
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which was not significantly more susceptible than B. ovis PA
(Table 3).
Both B. ovis PA and B. abortus RB51 rough strains were
highly resistant to 1 h of exposure to 0.1 mg ml
1 sodium
deoxycholate, while all the B. ovis PA Omp25/Omp31 family
mutant strains, except the omp31 strain, showed percentages
of survival to this detergent that were significantly lower than
that observed for parental B. ovis PA (Table 3). The omp25c
and omp22 mutant strains were the most susceptible strains
(P  0.0005), with percentages of survival of 39.21%  7.92%
and 30.68%  3.60%, respectively, and none of the comple-
mented mutant strains recovered the resistance levels observed
for the parental strain, proving to be as susceptible to deoxy-
cholate as the corresponding mutant strains were (Table 3).
Regarding susceptibility to hydrogen peroxide, all the B. ovis
PA Omp25/Omp31 family mutant and complemented mutant
strains were more susceptible (P  0.0005) than the parental
strain (Table 3). B. abortus RB51 was more resistant (P 
0.005) than B. ovis PA and therefore more resistant than the B.
ovis PA mutants (Table 3). Complementation of the mutant
strains with the corresponding wild-type genes failed to restore
the behavior of the parental strain and, in particular, the com-
plemented mutant strain B. ovis PNV25cA-com was even more
susceptible (P  0.0005) to hydrogen peroxide than its corre-
sponding mutant strain, PNV25cA.
Exposure for 4 h to nonimmune ram serum strongly reduced
the viability of B. abortus RB51 (survival of 25.73%  4.84%),
with no dramatic effect on the survival of parental B. ovis PA
(survival of 85.52%  5.20%) (P  0.0005 for the statistical
differences between both strains) being observed (Table 3). All
the B. ovis PA Omp25/Omp31 family mutant strains were more
susceptible than the parental strain to the bactericidal action of
serum, with the omp22 mutant strain displaying more defects
in this regard (survival of 25.38%  3.98%; P  0.0005). The
properties of the complemented strain B. ovis PNV25A-com
were similar to those of the parental strain. By contrast, the
complementation of the omp31, omp25c, omp25d, and
omp22 mutant strains with the corresponding wild-type genes
did not restore the survival capacities of the parental strain to
nonimmune ram serum, with strain B. ovis PN25cA-com prov-
ing to be even significantly more susceptible to the bactericidal
action of ram serum than the corresponding omp25c mutant
strain (survival of 17.51%  14.17% versus 55.68%  7.42%;
P  0.0005) (Table 3).
Role of the proteins of the Omp25/Omp31 family in the
virulence of B. ovis PA in mice. The virulence of the B. ovis PA
Omp25/Omp31 family mutant strains obtained in this work was
evaluated in a BALB/c mouse model by intraperitoneal inoc-
ulation of 5  106 CFU/mouse and subsequent determination
of bacterial counts in spleen at selected intervals p.i. Mice
inoculated with the B. ovis PA parental strain were used as
controls. The exact inoculation doses (CFU/mouse) for each B.
ovis strain, determined retrospectively, were as follows: for
parental PA, 5.40  106; for PNV31A, 0.65  106; for
PNV25A, 4.40 106; for PNV25cA, 5.50 106; for PNV25dA,
8.50  106; and for PNV22A, 7.00  106.
The omp25 and omp25c mutant strains showed kinetics
of infection in spleen similar to that displayed by the parental
strain, with maximum levels of infection between weeks 2 and
5 p.i. declining slowly thereafter until the end of the experi-
ment at week 11 p.i. (Fig. 4A). Mutant strain PNV31A reached
a level of splenic infection equivalent to that seen in the pa-
rental strain at week 1 p.i. and also between weeks 7 and
11 p.i. However, maximum spleen colonization was about 1
log lower for the omp31 mutant than for parental B. ovis
PA (P  0.0005 and P  0.005 at weeks 3 and 5 p.i.,
respectively) (Fig. 4B).
In contrast, the absence of Omp25d and Omp22 from the
OM of B. ovis PA dramatically reduced the virulence of the
bacterium, as demonstrated by the striking decrease in splenic
colonization observed for mutant strains PNV25dA and
PNV22A compared to that observed for parental B. ovis PA
(Fig. 4A). In spite of giving bacterial counts about 2 logs higher
than those for the parental strain at week 1 p.i. (P  0.0005),
the omp25d mutant strain underwent a quick reduction in
splenic bacterial counts after week 2 p.i., being 5.5 logs lower
than those detected for the parental strain at 3 weeks p.i. (P 
0.0005) and undetectable thereafter in any mice (Fig. 4A).
Even more dramatic was the attenuation observed for the
omp22 mutant strain, since this strain was isolated from only
two out of five mice at week 1 p.i., and it was completely
cleared from spleens after week 2 p.i. (Fig. 4A). The comple-
mented mutant strains B. ovis PNV25dA-com and PNV22A-
com inoculated into mice at doses of 5 106 CFU/mice had
bacterial counts in spleen at weeks 2 and 9 p.i. that were similar
to those observed for the corresponding mutant strains at the
same times p.i. (data not shown).
FIG. 4. Kinetics of splenic infection of parental B. ovis PA (A and B), and the mutant strains with the genes omp25, omp25c, omp25d, and
omp22 (A) and omp31 (B) inactivated. Mice were inoculated intraperitoneally with 5  106 CFU. Results are expressed as the mean  SD
(n 	 5) of the log CFU/spleen.
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DISCUSSION
In this work, five mutant strains with the omp31, omp25,
omp25c, omp25d, and omp22 genes inactivated were obtained
from virulent B. ovis PA and characterized. Inactivation of
omp25b and omp31b was not attempted in B. ovis, since
omp25b is included in a 15-kb DNA fragment that is absent
from this Brucella species (46) and omp31b has a nucleotide
substitution that generates a stop codon that would truncate
the encoded protein, probably preventing its localization in the
OM (46). All the genetically modified B. ovis PA strains af-
forded the expected results in the genotypic characterization
and behaved as the parental strain in conventional bacterio-
logical tests currently used for Brucella typing. As reported in
Results, the absence of the target OMP in the corresponding
mutant strains and the recovery of its synthesis in the respec-
tive strain complemented with the wild-type gene were con-
firmed by reactivity with MAbs (Fig. 2) or antisera (unpub-
lished results). The exceptions were mutant B. ovis PNV25dA
and the corresponding complemented strain PNV25d-com,
since the Omp25d antiserum did not react with either of these
two strains, but neither did they react with the parental strain.
The B. ovis PA mutant strain with omp25d inactivated dis-
played behavior similar to that of the parental strain as regards
in vitro growth, in both solid and liquid culture media (Fig. 1A
and data not shown). Accordingly, the marked reduction in
virulence observed for this B. ovis mutant in mice (Fig. 4A)
cannot be justified on this basis. The in vitro growth of the
omp22 strain was also similar to that of the parental strain,
with the exception of a marked reduction in viability in the
stationary phase (Fig. 1B). This fact could denote difficulties
for the bacterium to grow in deprived media and/or at acid pH,
conditions that it would find inside the host cells, and this could
be related to the attenuation observed for the B. ovis PA strain
lacking Omp22 (Fig. 4A).
The integrity of the OM is essential for the viability of
bacteria. Thus, the removal of one OMP of the Omp25/Omp31
family might lead to a compensatory effect by increasing the
synthesis of other members of this family. The possibility of a
compensatory effect, analyzed only for the levels of Omp25
and Omp31 (major OMPs for which MAbs are available), was
detected only in the omp31 mutant strain. In this strain, the
levels of Omp25 seemed to be increased (Fig. 2B and D), as
was also the case for the strain complemented with wild-type
omp31 (Fig. 2B and D), which also seemed to have levels of
Omp31 lower than those for parental B. ovis PA. However,
these results should be considered with caution, since the syn-
thesis of the other members of the Omp25/Omp31 family was
not evaluated and the limitations to immunological detection
of the protein must be taken into account (i.e., the reactivity of
a MAb may be influenced by the particular conformation of
the protein in each strain, even under the denaturing condi-
tions of sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis). The existence of a compensatory effect has been
described for the genus Bartonella for a group of homologous
proteins that are also homologous to the Brucella spp. Omp25/
Omp31 family (39). Additionally, there is a work reporting that
the inactivation of omp25c, omp25d, and omp22 in B. suis 1330
seems to increase the levels of Omp25b (42), but this effect is
not possible in B. ovis, since this Brucella species lacks Omp25b
(46). A B. suis strain with the omp31 gene inactivated was not
obtained in this previous study (42), and it is therefore impos-
sible to compare the results obtained in our work with B. ovis.
The results for the reactivity in iELISA of MAbs specific to
Omp25 and Omp31 with the B. ovis PA Omp25/Omp31 family
mutant strains suggest that the conformation of Omp31 and
especially of Omp25 would be modified when some of the
other OMPs of the family are removed from the OM. The
change in the conformation, which also indicates alterations in
the OM, was particularly evident when the anti-Omp25 MAbs
C09 and F04 were used. The specific epitope of MAb C09
seems to be either less exposed at the surface or disposed in a
different conformation in some mutant strains compared to
what is seen for parental B. ovis PA (Fig. 2D). The reactivity of
MAb F04 in iELISA has previously been shown to be stronger
with Omp25 from B. melitensis than with the B. ovis protein,
and no reactivity was detected between this MAb and recom-
binant E. coli bearing the B. ovis Omp25 protein at the surface
(10). Surprisingly, although this MAb did not react with pa-
rental B. ovis PA or with mutant strain B. ovis PNV25A, it
reacted strongly with the other B. ovis PA Omp25/Omp31
family mutants (Fig. 2D). In light of the results obtained from
Western blotting and iELISA with the anti-Omp25 MAb C09,
this higher reactivity of MAb F04 (except perhaps for mutant
PNV31A) does not seem to be related to increased levels of
Omp25 but rather seems related to a different topology of
Omp25, suggesting modifications of the OM in these B. ovis
strains.
Accordingly, the OM alterations detected by reactivity with
the MAbs specific for Omp25 and Omp31 do not by them-
selves justify the marked reduction in virulence observed with
mice for the omp25d and omp22 mutant strains, since the
omp25c mutant strain exhibited a similar pattern of reactivity
and was not attenuated in mice (Fig. 4A).
The autoagglutination properties could not be related with
either virulence or the rough phenotype, since parental rough
B. ovis PA and the attenuated strains B. ovis PNV25dA and
PNV22A did not agglutinate, while rough B. abortus RB51
settled rapidly (Fig. 3 and data not shown). Taking into ac-
count that the omp31 mutant of B. ovis PA displayed an
autoagglutination pattern similar to that observed for B. abor-
tus RB51 (Fig. 3) and that it has been shown that B. abortus
lacks Omp31 (49, 51), the autoagglutination phenomenon of B.
abortus RB51 could be related to the rearrangements of the
OM caused by the absence of Omp31. However, the possibility
of other differences in the OM, related or not to the Omp25/
Omp31 family, that might help to explain the different auto-
agglutination properties of both strains cannot be ruled out. In
this respect, other divergences between B. abortus and B. ovis
with respect to the members of the Omp25/Omp31 family have
been described previously (i.e., the absence of Omp31b and the
presence of Omp25 of a smaller size in B. ovis) (10, 46). It has
been also observed that the presence of O-polysaccharide
chains in LPS prevents the autoagglutination phenomenon,
since other smooth strains, including smooth B. abortus 2308,
from which rough strain RB51 derives, remain in suspension
(data not shown).
The particular properties of the OM are thought to be re-
sponsible for the resistance of Brucella spp. to the bactericidal
action of cationic peptides compared to what is seen for other
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gram-negative bacteria, such as enterobacteria (27, 37, 38).
This resistance has been associated in part with the presence of
O-polysaccharide chains in smooth strains, which would reduce
the surface exposure of inner anionic groups (38), although the
core-lipid A complex also plays a major role (33, 38). As in
previous reports (27, 28, 38, 43), polymyxin B was used in this
work to determine the stability of the OM and also as an
indicator of the susceptibility of the B. ovis PA mutants to the
bactericidal effect mediated by cationic peptides in the host.
Surprisingly, rough parental B. ovis PA was much more resis-
tant to a 1-h exposure to 1 mg/ml polymyxin B than rough B.
abortus RB51, which did not survive this treatment (Table 3),
and it was even slightly more resistant than smooth B. abortus
2308 (data not shown). The discrepancies with the results de-
scribed in other works reporting that B. ovis Reo 198 is more
susceptible to polymyxin B than smooth B. abortus S19 and
behaves like rough B. abortus 45/20 (28, 38) might be related to
the slight differences between the experimental protocols
and/or the different B. ovis and B. abortus strains used. It
should be noted that B. ovis Reo 198, employed in other works,
is an atypical B. ovis strain, since it does not require a CO2
atmosphere or serum supplementation in the culture medium
to grow and it is in addition an avirulent strain (28, 37, 38). In
any case, results presented in this work regarding polymyxin B
susceptibility reveal differences in the OM properties between
B. abortus RB51 and B. ovis PA that do not depend on the
presence or absence of O-polysaccharide chains at the surface,
since both strains exhibit a rough phenotype.
Regarding the B. ovis PA Omp25/Omp31 family mutant
strains, a higher susceptibility to polymyxin B cannot explain
the attenuation observed in mice for the omp25d and
omp22 B. ovis PA mutant strains, since they behaved like the
parental strain (Table 3) and the fully virulent omp25c mutant
was significantly more susceptible. However, the possibility
that the omp25d and omp22 strains might be more suscep-
tible than parental B. ovis PA to other bactericidal cationic
peptides present in mammals cannot be ruled out. On the
other hand, the complemented strain PNV25cA-com, which
recovered the synthesis of Omp25c but at levels higher than
those observed for the parental strain (unpublished results),
was significantly more susceptible to polymyxin B than the
corresponding mutant strain, suggesting that balanced levels
of Omp25c would be required for the stability of the B. ovis
PA OM.
Again, no explanation for the attenuation of the omp25d
and omp22 strains was found on the basis of susceptibility to
sodium deoxycholate, since both strains, although more sus-
ceptible than the parental strain (Table 3), did not show any
differences with the omp25c strain, which is fully virulent in
mice (Fig. 4A). Mutant strain PNV25A was also more suscep-
tible to this anionic detergent, and complementation of the
four susceptible mutant strains with the respective wild-type
genes did not restore the resistance properties of parental B.
ovis PA in any case. Since recoveries of the synthesis of
Omp25, Omp25c, and Omp22 were detected in the corre-
sponding complemented strains (Fig. 2 and unpublished re-
sults), these results again suggest that balanced levels of the
members of the Omp25/Omp31 family would be important to
maintain the stability of the OM.
In the present work, susceptibility to hydrogen peroxide was
selected as an indicator both of the stability of the OM and of
the ability of the B. ovis PA Omp25/Omp31 family mutant
strains to resist killing by the oxygen-dependent bactericidal
mechanisms of phagocytes. All the B. ovis mutants, and also all
the complemented mutants, were significantly more suscepti-
ble to H2O2 than the parental strain, again showing the diffi-
culties involved in restoring the phenotype of parental B. ovis
PA by complementation with the wild-type gene when the
encoded protein is located in the OM. The loss of virulence
caused by the absence of Omp25d or Omp22 from the B. ovis
PA surface cannot be explained in terms of a higher suscepti-
bility to hydrogen peroxide, although the possibility that the
omp25d and omp22 mutants might be more susceptible to
intracellular killing mediated by other oxygen-dependent
mechanisms cannot be excluded. All the B. ovis strains, includ-
ing the parental strain, were also more susceptible than B.
abortus RB51 (Table 3), again showing up the differences be-
tween rough strains from different Brucella species.
Brucella spp. are also at least partially resistant to killing
mediated by the action of host nonimmune serum (1, 14, 20,
24, 25), which may contribute to virulence. Since OM proper-
ties may influence the behavior of Brucella spp. towards non-
immune serum to a considerable extent, we have evaluated the
role of the members of the Omp25/Omp31 family in the sur-
vival of B. ovis PA in the presence of nonimmune ram serum.
Although the virulence assays were performed in a murine
model, ram serum was selected for susceptibility studies be-
cause ram is the preferred host for B. ovis and because of the
difficulty involved in obtaining the required amount of serum
from mice.
Exposure for 4 h to nonimmune ram serum dramatically
reduced the viability of rough B. abortus RB51, while the sus-
ceptibility of rough B. ovis PA was very low (Table 3). Smooth
B. abortus 2308 has previously been reported to be more re-
sistant than the rough strains of the same species to the bac-
tericidal effect of bovine and human nonimmune serum (1, 14,
20, 25), and these differences have been attributed to the pres-
ence of O-polysaccharide chains in the LPS of smooth B.
abortus 2308 (1, 14, 20, 25). Nevertheless, while rough B. abor-
tus strains are susceptible to exposure to human nonimmune
serum, rough B. melitensis mutant strains are not (25). There-
fore, in addition to the presence or absence of O-polysaccha-
ride chains in the LPS, other differences, probably in the bac-
terial surface, must exist between the Brucella species to
account for their different levels of susceptibility to nonim-
mune serum. This idea is also supported by the differences
between B. ovis PA and B. abortus RB51 found in this work
(Table 3).
Considering that B. abortus lacks a DNA fragment of about
25 kb that includes omp31 (48, 49, 51), the absence of Omp31
or other proteins encoded in this DNA fragment in B. abortus
has been suggested as a possible explanation for the differences
between B. melitensis and B. abortus as regards their suscepti-
bilities to nonimmune serum (25). In the present work, we
observed that the omp31 mutant strain was more susceptible
to killing by nonimmune ram serum than parental B. ovis PA,
but it was also significantly more resistant than rough B. abor-
tus RB51 (Table 3). Accordingly, by itself the absence of
Omp31 in B. abortus RB51 does not explain its higher suscep-
tibility to the bactericidal effect of nonimmune ram serum, and
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hence other differences, known or unknown, between the B.
abortus and B. ovis rough strains used in this work must be
involved in their different susceptibilities. In this respect, it
should be noted that between the two Brucella species, in
addition to the absence of Omp31 in B. abortus, there are other
differences regarding the members of the Omp25/Omp31 fam-
ily, such as the absence of Omp31b in B. ovis (46) and the
presence of Omp25 of a smaller size in B. ovis (10).
The absence of Omp22 from the OM of B. ovis PA elicited
an important reduction in its resistance to killing by nonim-
mune ram serum (Table 3), which could account at least in part
for the almost complete loss of virulence observed in the mu-
rine model for the omp22 mutant strain (Fig. 4A). On the
other hand, the attenuation of the omp25d mutant strain
(Fig. 4A) cannot be explained exclusively on the basis of its
higher susceptibility to nonimmune serum, since it was as sus-
ceptible as the fully virulent omp25c strain (Table 3; Fig. 4A).
Again, complementation of the mutant strains with the corre-
sponding wild-type genes of the Omp25/Omp31 family did not
restore the resistance to nonimmune ram serum observed for
parental B. ovis PA (Table 3), even in complemented mutant
strains where the synthesis of the removed protein was de-
tected. Additionally, strain PNV25cA-com was significantly
more susceptible than the corresponding PNV25cA mutant
strain (Table 3), which again shows that a tight balance of the
members of the Omp25/Omp31 family is essential for main-
taining the properties of the OM.
Regarding the role of the members of the Omp25/Omp31
family in the virulence of B. ovis PA in mice, removal of
Omp31 from the OM had no dramatic effect on the persistence
of the bacterium in spleen (Fig. 4B). The only remarkable
effect was that in comparison with the parental strain, the
mutant strain B. ovis PNV31A showed a reduction of about 1
log in the maximum levels of splenic colonization, which were
obtained between weeks 2 and 5 p.i. (Fig. 4B). The fact that
Omp31 has no relevant effect in the virulence of B. ovis, in spite
of being a major OMP, is not surprising, considering that this
protein is not synthesized in virulent B. abortus (49, 51) and
that it is not essential for the virulence of B. melitensis Rev.1 in
either the murine or sheep model (8, 31). It has been shown
that Omp31 functions as a hemin-binding protein in B. meliten-
sis, B. suis, and B. ovis, and its synthesis seems to be increased
under iron-limiting conditions in the culture medium (15).
Despite the relevance that the hemin-binding capacity of
Omp31 might have for the virulence of Brucella spp., the re-
sults obtained in this work regarding the virulence in mice of
the B. ovis PA omp31 mutant (Fig. 4B), together with those
reporting that Omp31 is not necessary for the virulence of B.
abortus or B. melitensis Rev.1 (8, 31, 49, 51), suggest that
Omp31 would not be essential for iron uptake. However, the
other members of the Omp25/Omp31 family might also have
hemin-binding properties that would compensate the effect of
the absence of Omp31 from the OM. In this respect, it should
be noted that the hemin-binding protein HbpA from Bartonella
quintana shares 32% amino acid sequence identity with
Omp31 from B. melitensis (6) and that other four proteins
homologous to HbpA and thought to be able to bind hemin
exist in B. quintana (39).
The omp25 and omp25c mutant strains displayed kinetics
of splenic colonization similar to that observed for the parental
strain (Fig. 4A), and therefore Omp25 and Omp25c do not
play an important role in the virulence of B. ovis PA, at least
under our experimental conditions. The full virulence of the
omp25c mutant strain was surprising, considering that it was
the B. ovis PA mutant that showed in the tests performed in
this work the most evident alterations of the OM (Fig. 2 and 3;
Table 3) and that omp25c is highly conserved, with almost
identical nucleotide sequences, in all Brucella species (46). On
the other hand, the results obtained with the omp25 strain
differ from those obtained in a previous work with a omp25
mutant of B. ovis LSU99 (18). The differences between the two
studies might be related to the different genetic backgrounds of
the respective B. ovis parental strains or to differences in the
doses or routes of infection employed in each case. The first of
these options is the most likely, since the infection levels
reached in spleen with the parental strains were similar in both
studies and it has been demonstrated that B. ovis PA splenic
growth curves after intravenous or intraperitoneal infection
are almost identical (34).
Some indirect evidence has been reported previously about
the possible involvement of Omp25 in the virulence of Brucella
spp., but this evidence might be dependent on the host and/or
Brucella species. Thus, on one hand it has been shown that
Omp25 of B. suis inhibits the production of TNF- in human
macrophages (35) and that it is involved in the release of
periplasmic proteins in acidic conditions (3) and that B. abortus
attenuated mutants with the bvrS-bvrR two-component regu-
latory system impaired do not synthesize Omp25 (32). On the
other hand, other works have shown that the protein factor
responsible for the inhibition of the TNF- production is not
active in mouse macrophages (5) and that attenuated mutants
of B. suis bvrS-bvrR showing defects in intracellular multipli-
cation in human macrophages do not present lower Omp25
levels (42).
As discussed above for each test, the marked reduction in
virulence observed for the omp25d mutant strain cannot be
explained on the basis of the results obtained in any of the
analyses regarding the OM properties performed here. Ac-
cordingly, Omp25d could be directly involved in the penetra-
tion and/or survival of B. ovis inside host cells. The same
reasoning could be applied to hypothesize the role of Omp22
in virulence, although as discussed before the higher suscepti-
bility of the omp22 mutant strain to nonimmune serum and
its difficulty in surviving during the stationary phase of growth
could be related to the striking degree of attenuation observed
for this B. ovis PA mutant strain in mice (Fig. 4A). It should
also be mentioned that B. abortus attenuated mutants with the
bvrS-bvrR two-component regulatory system impaired do not
synthesize Omp22 (32).
Complementation of omp25d and omp22 mutant strains
of B. ovis PA with the corresponding wild-type genes did not
recover the virulence or the OM properties of the parental
strain. Although the possibility of a spontaneous mutation be-
ing the origin of the defects observed for these mutant strains
cannot be completely disregarded, it should be noted that a
clear rho-independent transcription terminator is located
downstream from all the genes of the Omp25/Omp31 family,
and hence the probability of a polar effect on a downstream
gene in B. ovis PNV25dA and PNV22A seems to be very low.
Moreover, the gene downstream from omp22 is located in the
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opposite orientation in the Brucella spp. genome. Additionally,
by reactivity with specific antisera (unpublished results),
Omp25d has not been detected in the complemented strain
PNV25dA-com, and very low levels of Omp22 were detected in
the complemented strain PNV22A-com in comparison to what
was detected for the parental strain. Complementation in trans
of Brucella mutant strains with wild-type genes coding for
OMPs has frequently proved unsuccessful (3, 18, 44) due to the
difficulty involved in recovering levels of the surface protein
exactly the same as those found in the parental strain, which is
probably essential for maintaining the integrity of the OM,
especially in rough strains. This was clearly seen in comple-
mented strain PNV25cA-com, which recovered the synthesis of
Omp25c—although at levels higher than those found for pa-
rental B. ovis PA (unpublished results)—but had even more
OM defects (Table 3) than the corresponding omp25c mutant
strain.
The results reported here are pioneering in the study of the
virulence factors involved in the pathogenicity of B. ovis, which
unlike rough mutant strains obtained from smooth virulent
Brucella spp. (1, 26, 30, 40, 45) is a natural rough Brucella
species that is virulent in its preferred host and in animal
models. Taking into account that Omp25d and Omp22 are
essential for the virulence of B. ovis PA in mice and that both
proteins are highly conserved with almost identical amino acid
sequences in all Brucella species (46), the possibility of a role in
the virulence of the other Brucella species should be consid-
ered. It would be also of great interest to determine the rele-
vance for the virulence of B. ovis in rams not only of Omp25d
and Omp22 but also of the other members of the Omp25/
Omp31 family. These aspects, together with the role of these
OMPs in intracellular survival, will be addressed in a forth-
coming study to be conducted in our laboratory.
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